Skip to main content

Independent. Not-for-profit. Evidence based.

Log in

Sign up

Don't miss out on the latest news, evidence and CPD opportunities on medicines and medical tests - sign up today.

My account

Log in details

My subscriptions

Add subscriptions

My favourites

RADAR

NPS RADAR provides health professionals with timely, independent evidence-based information on new drugs and medical tests and changes to listings on the Pharmaceutical Benefits Scheme and Medicare Benefits Schedule.

Latest full reviews View all

Outmanoeuvring hepatitis C

  • 01 Apr 2016
  • 3 min read

From 1 March 2016 several new direct-acting antiviral regimens became available on the PBS in a major advance in chronic HCV therapy

Sofosbuvir treatment combinations for chronic hepatitis C

  • 01 Apr 2016
  • 11 min read

Now PBS listed as a first-line interferon-free treatment option for chronic HCV genotype 1

Ledipasvir with sofosbuvir fixed-dose combination for chronic hepatitis C

  • 01 Apr 2016
  • 8 min read

Now PBS listed as a first-line, interferon-free treatment option for chronic HCV genotype 1

Daclatasvir with sofosbuvir, with or without ribavirin, for chronic hepatitis C

  • 01 Apr 2016
  • 10 min read

Now PBS listed as a first-line interferon-free combination treatment option for chronic HCV genotypes 1 and 3

Latest In Brief View all

Strontium ranelate PBS listing deleted

  • 19 Jul 2016
  • 2 min read

Palliative care items: simplified PBS listings and restriction changes

  • 25 May 2016
  • 2 min read

Itraconazole (Lozanoc) for systemic fungal infections

  • 01 Apr 2016
  • 1 min read

Brinzolamide with brimonidine tartrate (Simbrinza): Restricted Benefit listing

  • 01 Dec 2015
  • 4 min read

Pharmacological therapies in Australia for type 2 diabetes

  • 01 Dec 2015
  • 3 min read

Wrap Up

April 2016 new listings wrap-up

  • 01 Apr 2016
  • 4 min read